You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ak105

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor Female Trial (AK105, Anlotinib HCl, Albumin Paclitaxel)

Not yet recruiting
  • Breast Neoplasm Female
  • AK105
  • +2 more
  • (no location specified)
Jul 11, 2022

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

Hepatocellular Carcinoma Trial in Beijing (AK105, Anlotinib Hydrochloride)

Active, not recruiting
  • Hepatocellular Carcinoma
  • AK105
  • Anlotinib Hydrochloride
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 7, 2020

NSCLC Trial in Guanzhou (AK112, Pemetrexed, Paclitaxel)

Recruiting
  • NSCLC
  • Guanzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jan 30, 2021

Nasopharyngeal Carcinoma Trial in Hangzhou (AK105, Cisplatin, Gemcitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • AK105
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Jan 30, 2021

Advanced Head, Neck and Chest Cancer Trial in Beijing (AK105, Anlotinib)

Recruiting
  • Advanced Head, Neck and Chest Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences and Peking
Jun 21, 2020

Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors Trial in China (AK105, Anlotinib)

Unknown status
  • Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
  • Beijing, Beijing, China
  • +6 more
Jun 16, 2020

MSI-H or dMMR Advanced Solid Tumors Trial in China (AK105, Anlotinib)

Unknown status
  • MSI-H or dMMR Advanced Solid Tumors
  • Beijing, Beijing, China
  • +8 more
Feb 28, 2020

Solid Tumor, Lung Cancer, HCC Trial in Hangzhou (AK105)

Unknown status
  • Solid Tumor
  • +2 more
  • AK105
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Zhejiang University
Nov 19, 2019

Lung Cancer Non-small Cell Stage IV, Squamous Cell Lung Cancer Trial in Shanghai, Beijing (AK105, Paclitaxel, Carboplatin)

Unknown status
  • Lung Cancer Non-small Cell Stage IV
  • Squamous Cell Lung Cancer
  • AK105
  • +3 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 6, 2019

Lung Cancer Non-small Cell Stage IV Trial in Beijing, Shanghai (AK105, carboplatin, pemetrexed)

Unknown status
  • Lung Cancer Non-small Cell Stage IV
  • AK105
  • +3 more
  • Beijing, Beijing, China
  • +1 more
Mar 6, 2019